About Sonic Incytes
Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such as MASLD and MASH
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Vancouver, BC
- Founded
- 2017
- Company type
- Privately Held
- Company profile name
- Sonic Incytes Medical Corp.
Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The company's flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.
Company locations
936 W 8th Ave, Vancouver, BC V5Z 1E5, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
Business areas
- Health Care
- Medical Device
On LinkedIn
- Followers
- 3,283
- People linked to this company
- 45
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
10,581,899 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.